Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence

In this review, we briefly outline our current knowledge on the epidemiology, outcomes, and pathophysiology of heart failure (HF) with mid-range ejection fraction (HFmrEF), and discuss in more depth the evidence on current treatment options for this group of patients. In most studies, the clinical b...

Full description

Bibliographic Details
Main Authors: Eleni-Evangelia Koufou, Angelos Arfaras-Melainis, Sahil Rawal, Andreas P. Kalogeropoulos
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
heart failure
heart failure with mid-range ejection fraction
therapy
left ventricular systolic function
beta blockers
angiotensin-converting enzyme inhibitors
Online Access:https://www.mdpi.com/2077-0383/10/2/203

Internet

https://www.mdpi.com/2077-0383/10/2/203

Similar Items